We are live on
!
Find out more
AYLA
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
AYLA
Delisted
AYLA was delisted on the 18th of January, 2023.
11 hedge funds and large institutions have $22.3M invested in Ayala Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
57% more funds holding
Funds holding: 7 → 11 (+4)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
15% more capital invested
Capital invested by funds: $19.4M → $22.3M (+$2.89M)
Holders
11
Holders Change
+4
Holders Change %
+57.14%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Sio Capital Management
New York
|
+$4.76M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.55M |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$500K |
| 4 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$214K |
| 5 |
Morgan Stanley
New York
|
+$59.6K |
Top Sellers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$1.25M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$661K |
| 3 |
Millennium Management
New York
|
-$124K |